News
26 May, 2022 26 May, 2022 Position of the Transparency Council – Olumiant (baricitinibum)
read more26 May, 2022 Position of the Transparency Council – Tecentriq (atezolizumabum)
read more26 May, 2022 Opinion of the Transparency Council – donepezilum
read more26 May, 2022 Opinion of the Transparency Council – rivastigminum
read more26 May, 2022 Opinion of the Transparency Council – quetiapinum
read more26 May, 2022 Position of the Transparency Council – PET/MRI – for oncology indications
read more26 May, 2022 Position of the Transparency Council – PET/MRI – for neurological indications
read more26 May, 2022 Position of the Transparency Council – PET/MRI – for neurological indications
read more26 May, 2022 Position of the Transparency Council – PET/MRI – for cardiac indications
read more24 May, 2022 The Meeting of the Transparency Council No. 21/2022 of 30.05.2022
read more23 May, 2022 The Meeting of the Tariffs Council No. 11/2022 of 24.05.2022
read more19 May, 2022 Invitation to participate in public consultations for non governmental organizations representing patients
read more18 May, 2022 Opinion of the Transparency Council – posaconazolum
read more18 May, 2022 Opinion of the Transparency Council – lacosamide
read more20 April, 2022 Free AOTMiT training – dates April/May 2022
read more30 March, 2022 Tariff Council meeting 6/2022 on 31.03.2022
read more28 March, 2022 Opinion of the President – “Programme for early detection of hearing and vision impairment among children aged 6 in the Municipality of Świebodzin for 2022-2024”
read more